BIORA THERAPEUTICS, INC. Quarterly Amortization of Intangible Assets in USD from Q2 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Biora Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2019 to Q3 2022.
  • Biora Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2022 was $0.000.
  • Biora Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2022 was $100K, a 85.7% decline year-over-year.
  • Biora Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $500K, a 44.4% decline from 2020.
  • Biora Therapeutics, Inc. annual Amortization of Intangible Assets for 2020 was $900K, unchanged from 2019.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $100K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $100K $0 -$200K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $300K $0 -$200K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $500K $100K -$200K -66.7% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-28
Q3 2021 $700K $0 -$200K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $900K $200K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $900K $200K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $900K $300K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $200K -$500K -71.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $200K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $200K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 $700K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $200K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.